Managing Schizophrenia Patients With Cardiometabolic Risk and Comorbidities

This presentation on managing schizophrenia patients with cardiometabolic risk and comorbidities reviews the various treatments for schizophrenia and their evidence base, efficacy, and adverse events; the importance of individualizing treatments and managing comorbidities associated with schizophrenia; and the optimal therapeutic methods for enhancing engagement of patients and their caregivers in treatment decision-making and how it can improve medication adherence.
Format: Adobe Acrobat (.pdf)
File Size: 1.12 MB
Released: March 23, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 
Independent Educational Activity

Related Content

Slides from a presentation that educates clinicians on the identification and management of tardive dyskinesia.

Christoph U. Correll, MD Robert O. Cotes, MD Released: May 11, 2022

Slides from a presentation that educates clinicians on antipsychotic treatment of schizophrenia.

Christoph U. Correll, MD Robert O. Cotes, MD Released: May 11, 2022

Slides from a presentation that educates clinicians on managing major depression.

Manish Jha, MD Greg W. Mattingly, MD Released: May 11, 2022

Slides from a presentation that educates clinicians on managing bipolar depression and mixed presentations

Charles DeBattista, MD Roger McIntyre, MD, FRCPC Released: May 9, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings